Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02966587
Title Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

prostate cancer

Therapies

Durvalumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.